Tyreoliberin (Trh) – The Regulatory Neuropeptide of Cns Homeostasis

[1] ALKEMADE A, UNMEHOPA UA, WIERSINGA WM, SWAAB DF, FLIERS E. Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. J Clin Endocrinol Metab. 2005; 90: 323-327.1550964510.1210/jc.2004-1430Search in Google Scholar

[2] BEHRMANN DL, BRESNAHAN JC, BEATTIE MS. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673. Exp Neurol. 1994; 126: 61-75.10.1006/exnr.1994.1042Search in Google Scholar

[3] BIDAUD I, LORY P, NICOLAS P, BULANT M, LADRAM A. Characterization and functional expression of cDNAs encoding thyrotropin-releasing hormone receptor from Xenopus laevis. Eur J Biochem. 2002; 269: 4566-4576.10.1046/j.1432-1033.2002.03152.xSearch in Google Scholar

[4] BOLER J, ENZMANN F, FOLKERS K, BOWSER CY, SCHALLY AV. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem Biophys Res Commun. 1969; 37: 705-710.10.1016/0006-291X(69)90868-74982117Open DOISearch in Google Scholar

[5] BORLONGAN CV, STAHL CE, REDEI E, WANG Y. Prepro-thyrotropin-releasing hormone 178-199 exerts partial protection against cerebral ischemia in adult rats. Neuroreport 1999; 10: 3501-3505.10.1097/00001756-199911260-0000710619633Search in Google Scholar

[6] BROOKS BR. A summary of the current position of TRH in ALS therapy. Ann N Y Acad Sci. 1989; 553: 431-461.10.1111/j.1749-6632.1989.tb46664.xSearch in Google Scholar

[7] BURGUS R, DUNN TF, DESIDERO D, GUILLEMIN R. Molecular structure of the hypothalamic hypophysiotropic TRF factor of ovine origin: mass spectrometry demonstration of the PCA-His-Pro- NH2 sequence. C R Acad Sci Hebd Seances Acad Sci D. 1969, 269; 1870-1873.Search in Google Scholar

[8] CARROLL AR, LAMB J, MONI R, GUYMER GP, FORSTER PI, QUINN RJ Myrtucommulones FI, phloroglucinols with thyrotropin-releasing hormone receptor-2 binding affinity from the seeds of Corymbia scabrida. J Nat Prod. 2008; 71: 1564-1568.10.1021/np800247u18771320Search in Google Scholar

[9] CHIAMOLERA MI, WONDISFORD FE. Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology. 2009; 150: 1091-1096.10.1210/en.2008-179519179434Search in Google Scholar

[10] CIOSEK J. Influence of thyroliberin on vasopressin and oxytocin release from the hypothalamoneurohypophysial system under in vivo and in vitro conditions. Postepy Hig Med Dosw. 2007; 61: 429-437.Search in Google Scholar

[11] CIOSEK J. Thyrotropin-releasing hormone (TRH): the biosynthesis, distribution, receptors and metabolism. Endokrynologia Polska 2004; 55 (5): 608-615.Search in Google Scholar

[12] DENG PY, PORTER JE, SHIN HS, LEI S. Thyrotropin-releasing hormone increases GABA release in rat hippocampus. J Physiol. 2006; 577: 497-511.10.1113/jphysiol.2006.118141189044216990402Search in Google Scholar

[13] ENGEL S, GERSHENGORN MC. Thyrotropin-releasing hormone and its receptors--a hypothesis for binding and receptor activation. Pharmacol Ther. 2007; 113: 410-419.10.1016/j.pharmthera.2006.09.00417123625Search in Google Scholar

[14] ENGEL S, NEUMANN S, KAUR N, MONGA V, JAIN R, NORTHUP J, GERSHENGORN MC. Low affinity analogs of thyrotropin-releasing hormone are super-agonists. J Biol Chem. 2006; 281: 13103-13109.10.1074/jbc.M600440200Search in Google Scholar

[15] FADEN AI, JACOBS TP, HOLADAY JW. Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats. N Engl J Med. 1981; 305: 1063-1067.10.1056/NEJM198110293051806Search in Google Scholar

[16] FADEN AI, KNOBLACH SM, CERNAK I, FAN L, VINK R, ARALDI GL, FRICKE ST, ROTH BL, KOZIKOWSKI AP. Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo. J Cereb Blood Flow Metab. 2003; 23: 342-354.1262130910.1097/01.WCB.0000046143.31247.FDSearch in Google Scholar

[17] FADEN AI, KNOBLACH SM, MOVSESYAN VA, LEA PM, CERNAK I. Novel neuroprotective tripeptides and dipeptides. Ann N Y Acad Sci. 2005; 1053: 472-481.10.1196/annals.1344.041Search in Google Scholar

[18] FADEN AI, MOVSESYAN VA, KNOBLACH SM, AHMED F, CERNAK I. Neuroprotective effects of novel small peptides in vitro and after brain injury. Neuropharmacology 2005; 49: 410-424.10.1016/j.neuropharm.2005.04.00115907950Open DOISearch in Google Scholar

[19] FADEN AI, SACKSEN I, NOBLE LJ. Structure-activity relationships of TRH analogs in rat spinal cord injury. Brain Res. 1988; 448: 287-293.10.1016/0006-8993(88)91265-6Search in Google Scholar

[20] FOLTYN W, NOWAKOWSKA-ZAJDEL E, DANIKIEWICZ A, BRODZIAK A. Hypothalamicpituitary- thyroid axis in depression. Psychiatr Pol. 2002; 36: 281-292.Search in Google Scholar

[21] GARY KA, SEVARINO KA, YARBROUGH GG, PRANGE AJ Jr, WINOKUR A. The thyrotropinreleasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics. J Pharmacol Exp Ther. 2003; 305: 410-416.10.1124/jpet.102.044040Search in Google Scholar

[22] GUTIERREZ-MARISCAL M, de GORTARI P, LOPEZ-RUBALCAVA C, MARTINEZ A, JOSEPHBRAVO P. Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety. Psychoneuroendocrinology. 2008; 33: 198-213.10.1016/j.psyneuen.2007.11.002Open DOISearch in Google Scholar

[23] HOLLENBERG AN. The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor. Thyroid. 2008;18: 131-139.1827901310.1089/thy.2007.0251Search in Google Scholar

[24] JAWORSKA-FEIL L, KAJTA M, BUDZISZEWSKA B, LESKIEWICZ M, LASOŃ W. Protective effects of TRH and its stable analogue, RGH-2202, on kainate-induced seizures and neurotoxicity in rodents. Epilepsy Res. 2001; 43: 67-73.10.1016/S0920-1211(00)00178-9Open DOISearch in Google Scholar

[25] JAWORSKA-FEIL, TURCHAN J, PRZEWŁOCKA B, BUDZISZEWSKA B, LEŚKIEWICZ M, LASOŃ W. Effects of pilocarpine- and kainate-induced seizures on thyrotropin-releasing hormone biosynthesis and receptors in the rat brain. J Neural Transm. 1999; 106: 395-407.10.1007/s007020050167Search in Google Scholar

[26] JAWORSKA-FEIL, TURCHAN J, PRZEWŁOCKA B, BUDZISZEWSKA B, LEŚKIEWICZ M, LASOŃ W. Effects of pentylenetetrazole-induced kindling on thyrotropin-releasing hormone biosynthesis and receptors in rat brain. Neuroscience 1999; 90: 695-704.1021517110.1016/S0306-4522(98)00446-1Search in Google Scholar

[27] KAUR N, MONGA V, LU X, GERSHENGORN MC, JAIN R. Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1. Bioorg Med Chem. 2007; 15: 433-443. 10.1016/j.bmc.2006.09.045Search in Google Scholar

[28] KREIDER MS, WOLFINGER BL, WINOKUR A. Systemic administration of kainic acid produces elevations in TRH in rat central nervous system. Regul Pept. 1990; 28: 83-93.10.1016/0167-0115(90)90066-62109340Open DOISearch in Google Scholar

[29] KUBEK MJ, KNOBLACH SM, SHARIF NA, BURT DR, BUTERBAUGH GG, FUSON KS. Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures. Ann Neurol. 1993; 33: 70-76.838819010.1002/ana.410330112Search in Google Scholar

[30] LASOŃ W. Endogenous anticonvulsant and neuroprotective agents. Przegl Lek. 2004, 61: 1263-1267.Search in Google Scholar

[31] LECHAN RM, FEKETE C. The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res. 2006;153: 209-235.10.1016/S0079-6123(06)53012-2Search in Google Scholar

[32] LUO L, STOPA EG. Thyrotropin releasing hormone inhibits tau phosphorylation by dual signaling pathways in hippocampal neurons. J Alzheimers Dis. 2004; 6: 527-536.1550537510.3233/JAD-2004-6510Search in Google Scholar

[33] LUO L, YANO N, MAO Q, JACKSON IM, STOPA EG. Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients. J Alzheimers Dis. 2002; 4: 97-103.1221413310.3233/JAD-2002-420412214133Search in Google Scholar

[34] MONGA V, MEENA CL, KAUR N, JAIN R. Chemistry and biology of thyrotropin-releasing hormone (TRH) and its analogs. Curr Med Chem. 2008; 15: 2718-2733.10.2174/0929867087862429121899163218991632Open DOISearch in Google Scholar

[35] NIE Y, SCHOEPP DD, KLAUNIG JE, YARD M, LAHIRI DK, KUBEK MJ. Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitro. Brain Res. 2005; 1054: 45-54.10.1016/j.brainres.2005.06.07716055093Search in Google Scholar

[36] NODA Y, FURUKAWA K, KOHAYAKAWA H, OKA M. Effects of RGH-2202 on behavioral deficits after focal cerebral ischemia in rats. Pharmacol Biochem Behav. 1995; 52: 695-699.858790710.1016/0091-3057(95)00134-ISearch in Google Scholar

[37] OKA M, ITOH Y, UKAI Y, YOSHIKUNI Y, KIMURA K. Protein kinases are involved in prolonged acetylcholine release from rat hippocampus induced by thyrotropin-releasing hormone analogue NS-3. J Neurochem. 1996; 66: 1889-1893.10.1046/j.1471-4159.1996.66051889.xSearch in Google Scholar

[38] PEKARY AE, SATTIN A, MEYERHOFF JL, CHILINGAR M. Valproate modulates TRH receptor, TRH and TRH-like peptide levels in rat brain. Peptides. 2004; 25: 647-658.10.1016/j.peptides.2004.01.01615165721Open DOISearch in Google Scholar

[39] PRZEWŁOCKA B, LABUZ D, MIKA J, LIPKOWSKI A, van LUIJTELAAR G, COENEN A, LASOŃ W. Protective effects of TRH and its analogues in chemical and genetic models of seizures. Pol J Pharmacol. 1997; 49: 373-378.9566039Search in Google Scholar

[40] PUNIAK MA, FREEMAN GM, AGRESTA CA, van NEWKIRK L, BARONE CA, SALZMAN SK. Comparison of a serotonin antagonist, opioid antagonist, and TRH analog for the acute treatment of experimental spinal trauma. J Neurotrauma 1991; 8: 193-203.10.1089/neu.1991.8.193Open DOISearch in Google Scholar

[41] RAJPUT SK, KRISHNAMOORTHY S, PAWAR C, KAUR N, MONGA V, MEENA CL, JAIN R, SHARMA SS. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog. Epilepsy Behav. 2009; 14: 48-53.10.1016/j.yebeh.2008.10.00618952198Open DOISearch in Google Scholar

[42] SATTIN A, PEKARY AE, BLOOD J. Escitalopram regulates expression of TRH and TRH-like peptides in rat brain and peripheral tissues. Neuroendocrinology. 2008; 88: 135-146.10.1159/000121595Search in Google Scholar

[43] SATTIN A, SENANAYAKE SS, PEKARY AE. Lithium modulates expression of TRH receptors and TRH-related peptides in rat brain. Neuroscience. 2002; 115: 263-273.10.1016/S0306-4522(02)00373-1Search in Google Scholar

[44] SCALABRINO GA, HOGAN N, O'BOYLE KM, SLATOR GR, GREGG DJ, FITCHETT CM, DRAPER SM, BENNETT GW, HINKLE PM, BAUER K, WILLIAMS CH, TIPTON KF, KELLY JA. Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone. Neuropharmacology. 2007; 52: 1472-1481.10.1016/j.neuropharm.2007.02.00317418282Open DOISearch in Google Scholar

[45] SCHIOTH HB, PRUSIS P, MUCENIECE R, MUTULIS F, MUTULE I, WIKBERG JE. Thyrotropin releasing hormone (TRH) selectively binds and activates the melanocortin 1 receptor. Peptides. 1999; 20: 395-400.10.1016/S0196-9781(98)00168-510447100Open DOISearch in Google Scholar

[46] SUN Y, LU X, GERSHENGORN MC. Thyrotropin-releasing hormone receptors -- similarities and differences. J Mol Endocrinol. 2003; 30: 87-97.10.1677/jme.0.03000871268393312683933Open DOISearch in Google Scholar

[47] SUN Y, ZUPAN B, RAAKA BM, TOTH M, GERSHENGORN MC. TRH-Receptor-Type-2- Deficient Mice are Euthyroid and Exhibit Increased Depression and Reduced Anxiety Phenotypes. Neuropsychopharmacology. 2008; Dec 10 [Epub ahead of print].10.1038/npp.2008.217Search in Google Scholar

[48] VALASSI E, SCACCHI M, CAVAGNINI F. Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis. 2008; 18, 158-168.1806141410.1016/j.numecd.2007.06.004Search in Google Scholar

[49] VERONESI MC, YARD M, JACKSON J, LAHIRI DK, KUBEK MJ. An analog of thyrotropinreleasing hormone (TRH) is neuroprotective against glutamate-induced toxicity in fetal rat hippocampal neurons in vitro. Brain Res. 2007; 1128: 79-85. 10.1016/j.brainres.2006.10.047Search in Google Scholar

[50] VETULANI J, NALEPA I. Antidepressants: past, present and future. Eur J Pharmacol. 2000; 405: 351-363.10.1016/S0014-2999(00)00565-3Search in Google Scholar

[51] VINK R, McINTHOSH TK, FADEN AI. Treatment with the thyrotropin-releasing hormone analog CG3703 restores magnesium homeostasis following traumatic brain injury in rats. Brain Res. 1988; 460: 184-188.10.1016/0006-8993(88)91221-8Search in Google Scholar

[52] WIKBERG JE, MUCENIECE R, MANDRIKA I, PRUSIS P, LINDBLOM J, POST C, SKOTTNER A. New aspects on the melanocortins and their receptors. Pharmacol Res. 2000; 42: 393-420.10.1006/phrs.2000.07251102370211023702Open DOISearch in Google Scholar

[53] WITTMANN G. Regulation of hypophysiotrophic corticotrophin-releasing hormone- and thyrotrophin-releasing hormone-synthesising neurones by brainstem catecholaminergic neurones. J Neuroendocrinol. 2008; 20: 952-960.1844512310.1111/j.1365-2826.2008.01748.x18445123Search in Google Scholar

[54] YANO N, LUO L. Effect of thyrotropin releasing hormone (TRH) on gene expressions in rat pancreas: approach by microarray hybridization. JOP. 2004; 5: 193-204.15254348Search in Google Scholar

[55] YARBROUGH GG. Fundamental molecular mechanism of the CNS effects of TRH. Trends Pharmacol Sci. 2003; 24: 617-618.10.1016/j.tips.2003.10.0011465430114654301Open DOISearch in Google Scholar

[56] ZENG H, SCHIMPF BA, ROHDE AD, PAVLOVA MN, GRAGEROV A, BERGMANN JE. Thyrotropin-releasing hormone receptor 1-deficient mice display increased depression and anxiety-like behavior. Mol Endocrinol. 2007; 21: 2795-2804. 10.1210/me.2007-004817666589Search in Google Scholar